Education | Health Care | Research | Site Map


Search:
Division of Infectious Disease
 
     
Division of Infectious Disease
 
Home
Fellowship Program
Clinical Programs
Penn CDC Prevention Epicenters Program
Clinical Trials
Penn CFAR
Botswana-UPenn Partnership
Seminars
Faculty
Adjunct Faculty
Administrative Contacts
Outpatient Clinics
News

 

Faculty

 
 

Emily Blumberg, M.D.

Dr. Blumberg specializes in infectious disease complications of solid organ transplantation. She is responsible for infectious diseases consultation in this population, which includes recipients of heart, liver, lung, kidney, and pancreas transplant and participates in related clinical research. Current research interests include transplantation in HIV infected individuals, use of newer antimicrobial agents in transplant recipients, and donor-derived infections.

Selected publications:

Hamilton KW, Abt PL, Rosenbach MA, Bleicher MB, Levine MS, Mehta J, Montgomery SP, Hasz RD, Bono BR, Tetzlaff MT, Mildiner-Early S, Introcaso CE, Blumberg EA. Donor derived Stronyloides stercoralis infections in renal transplant recipients. Transplantation 2011.

Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME. Outcomes of kidney transplantation in HIV infected recipients. New England Journal of Medicine 2010; 363:2004-14. Shiley KT, Gasink LB, Barton TD, Pfeiffenberger P, Olthoff KM, Blumberg EA. Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis. Liver Transpl. 2009 15:963-7.Gasink LB, Blumberg EA, Localio AR, Desai SS, Israni AK, Lautenbach E. The impact of donor hepatitis C virus seropositivity on survival in heart transplant recipients. JAMA 296:1843-50, 2006.

Halpern SD, Asch DA, Shaked A, Stock P, Blumberg EA. Inadequate Hepatitis B vaccination and post-exposure evaluation among transplant surgeons: prevalence, correlates, and implications. Annals of Surgery 244:305-9, 2006.

Shiley K, Gasink LB, Barton TD, Pfeiffenberger P, Olthoff KM, Blumberg EA. Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir versus ganciclovir prophylaxis. Liver Transplantation. 15:963-7, 2009.

Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME. Outcomes of kidney transplantation in HIV-Infected recipients. New England Journal of Medicine 363:2004-14, 2010.

Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG. HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year Outcomes. American Journal of Transplantation 8:355-65, 2008.

Gasink LB, Blumberg EA, Localio AR, Desai SS, Israni AK, Lautenbach E. The impact of donor hepatitis C virus seropositivity on survival in heart transplant recipients. JAMA 296:1843-50, 2006.

Gasink LB, Wurcell AG, Kotloff RM, Lautenbach E, Blumberg EA. Incomplete pneumococcal vaccination among potential lung transplant candidates. Chest 130:218-21, 2006.

Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E. Determinants of transplant surgeons willingness to provide organs to patients infected with Hepatitis B, Hepatitis C, or Human Immunodeficiency Viruses. American Journal of Transplantation 5:1319-25, 2005.

Contact:
Emily Blumberg, M.D.
Suite E, 3 Silverstein,3400 Spruce Street
Philadelphia, PA 19104-4283
blumbere@mail.med.upenn.edu
(215) 662-7066

Education:
Medical School: New York University
ID Training: Montefiore Medical Center/Albert Einstein College of Medicine
Academic Rank: Professor of Medicine